Bafna Pharmaceuticals reports standalone net loss of Rs 2.90 crore in the June 2016 quarter

Sales decline 8.48% to Rs 21.16 crore

Net Loss of Bafna Pharmaceuticals reported to Rs 2.90 crore in the quarter ended June 2016 as against net loss of Rs 1.19 crore during the previous quarter ended June 2015. Sales declined 8.48% to Rs 21.16 crore in the quarter ended June 2016 as against Rs 23.12 crore during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales21.1623.12 -8 OPM %3.648.69 -PBDT-1.94-0.10 -1840 PBT-2.95-1.12 -163 NP-2.90-1.19 -144

Powered by Capital Market - Live News